Differentiation of lung adenocarcinoma, pleural mesothelioma, and nonmalignant pulmonary tissues using DNA methylation profiles
- PMID: 19638575
- PMCID: PMC2755616
- DOI: 10.1158/0008-5472.CAN-09-1073
Differentiation of lung adenocarcinoma, pleural mesothelioma, and nonmalignant pulmonary tissues using DNA methylation profiles
Abstract
Pathologic differentiation of tissue of origin in tumors found in the lung can be challenging, with differentiation of mesothelioma and lung adenocarcinoma emblematic of this problem. Indeed, proper classification is essential for determination of treatment regimen for these diseases, making accurate and early diagnosis critical. Here, we investigate the potential of epigenetic profiles of lung adenocarcinoma, mesothelioma, and nonmalignant pulmonary tissues (n = 285) as differentiation markers in an analysis of DNA methylation at 1413 autosomal CpG loci associated with 773 cancer-related genes. Using an unsupervised recursively partitioned mixture modeling technique for all samples, the derived methylation profile classes were significantly associated with sample type (P < 0.0001). In a similar analysis restricted to tumors, methylation profile classes significantly predicted tumor type (P < 0.0001). Random forests classification of CpG methylation of tumors--which splits the data into training and test sets--accurately differentiated mesothelioma from lung adenocarcinoma over 99% of the time (P < 0.0001). In a locus-by-locus comparison of CpG methylation between tumor types, 1266 CpG loci had significantly different methylation between tumors following correction for multiple comparisons (Q < 0.05); 61% had higher methylation in adenocarcinoma. Using the CpG loci with significant differential methylation in a pathway analysis revealed significant enrichment of methylated gene-loci in Cell Cycle Regulation, DNA Damage Response, PTEN Signaling, and Apoptosis Signaling pathways in lung adenocarcinoma when compared with mesothelioma. Methylation profile-based differentiation of lung adenocarcinoma and mesothelioma is highly accurate, informs on the distinct etiologies of these diseases, and holds promise for clinical application.
Figures



Similar articles
-
Epigenetic profiles distinguish malignant pleural mesothelioma from lung adenocarcinoma.Cancer Res. 2009 Dec 1;69(23):9073-82. doi: 10.1158/0008-5472.CAN-09-1595. Epub 2009 Nov 3. Cancer Res. 2009. PMID: 19887624
-
Epigenetic profiles distinguish pleural mesothelioma from normal pleura and predict lung asbestos burden and clinical outcome.Cancer Res. 2009 Jan 1;69(1):227-34. doi: 10.1158/0008-5472.CAN-08-2586. Cancer Res. 2009. PMID: 19118007 Free PMC article.
-
Genome-wide DNA methylation analysis reveals a unique methylation pattern for pleural mesothelioma compared to healthy pleura and other lung diseases.Clin Epigenetics. 2024 Dec 3;16(1):176. doi: 10.1186/s13148-024-01790-z. Clin Epigenetics. 2024. PMID: 39627815 Free PMC article.
-
Applications of array-CGH for lung cancer.Methods Mol Biol. 2013;973:297-324. doi: 10.1007/978-1-62703-281-0_19. Methods Mol Biol. 2013. PMID: 23412798 Review.
-
Biomolecular and clinical practice in malignant pleural mesothelioma and lung cancer: what thoracic surgeons should know.Eur J Cardiothorac Surg. 2014 Oct;46(4):602-6. doi: 10.1093/ejcts/ezu048. Epub 2014 Mar 12. Eur J Cardiothorac Surg. 2014. PMID: 24623168 Free PMC article. Review.
Cited by
-
Genome-scale analysis of DNA methylation in lung adenocarcinoma and integration with mRNA expression.Genome Res. 2012 Jul;22(7):1197-211. doi: 10.1101/gr.132662.111. Epub 2012 May 21. Genome Res. 2012. PMID: 22613842 Free PMC article.
-
Infant growth restriction is associated with distinct patterns of DNA methylation in human placentas.Epigenetics. 2011 Jul;6(7):920-7. doi: 10.4161/epi.6.7.16079. Epigenetics. 2011. PMID: 21758004 Free PMC article.
-
Genetic deletion of caspase-2 accelerates MMTV/c-neu-driven mammary carcinogenesis in mice.Cell Death Differ. 2013 Sep;20(9):1174-82. doi: 10.1038/cdd.2013.38. Epub 2013 May 3. Cell Death Differ. 2013. PMID: 23645210 Free PMC article.
-
DNA methylation analysis reveals distinct methylation signatures in pediatric germ cell tumors.BMC Cancer. 2013 Jun 27;13:313. doi: 10.1186/1471-2407-13-313. BMC Cancer. 2013. PMID: 23806198 Free PMC article.
-
Targeting apoptotic caspases in cancer.Biochim Biophys Acta Mol Cell Res. 2020 Jun;1867(6):118688. doi: 10.1016/j.bbamcr.2020.118688. Epub 2020 Feb 19. Biochim Biophys Acta Mol Cell Res. 2020. PMID: 32087180 Free PMC article. Review.
References
-
- Holloway AJ, Diyagama DS, Opeskin K, et al. A molecular diagnostic test for distinguishing lung adenocarcinoma from malignant mesothelioma using cells collected from pleural effusions. Clin Cancer Res. 2006;12:5129–35. - PubMed
-
- Robinson BW, Lake RA. Advances in malignant mesothelioma. The New England journal of medicine. 2005;353:1591–603. - PubMed
-
- Nguyen GK, Akin MR, Villanueva RR, Slatnik J. Cytopathology of malignant mesothelioma of the pleura in fine-needle aspiration biopsy. Diagn Cytopathol. 1999;21:253–9. - PubMed
-
- Antman KH. Current concepts: malignant mesothelioma. The New England journal of medicine. 1980;303:200–2. - PubMed
-
- Chang MY, Sugarbaker DJ. Extrapleural pneumonectomy for diffuse malignant pleural mesothelioma: techniques and complications. Thorac Surg Clin. 2004;14:523–30. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- R01CA126831/CA/NCI NIH HHS/United States
- R01 ES006717/ES/NIEHS NIH HHS/United States
- P30ES00002/ES/NIEHS NIH HHS/United States
- P42ES05947/ES/NIEHS NIH HHS/United States
- P42 ES005947/ES/NIEHS NIH HHS/United States
- P50 CA097257/CA/NCI NIH HHS/United States
- T32ES007155/ES/NIEHS NIH HHS/United States
- R01CA105274/CA/NCI NIH HHS/United States
- R01 CA126939/CA/NCI NIH HHS/United States
- T32 ES007155/ES/NIEHS NIH HHS/United States
- R01ES006717/ES/NIEHS NIH HHS/United States
- P30 ES000002/ES/NIEHS NIH HHS/United States
- ES/CA06409/CA/NCI NIH HHS/United States
- R01 CA126831/CA/NCI NIH HHS/United States
- R01 CA105274/CA/NCI NIH HHS/United States
- R01 CA078609/CA/NCI NIH HHS/United States
- P50CA097257/CA/NCI NIH HHS/United States
- R01CA126939/CA/NCI NIH HHS/United States
- R01 CA100679/CA/NCI NIH HHS/United States
- R01CA52689/CA/NCI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
Research Materials